Last patient should complete dosing before the end of 2021 if Alkon is correct in first patient dosing by end of September or early October. Then add on up to 2 months for top line. Now its not impossible it goes quicker since most of the sites are now familiar with protocols and such but on the other hand no one knows how Covid could impact.
This being the 3rd trial, if results are clear in this population again, I do believe provisional approval could be granted while they likely run an even larger confirmatory trial. JMHO
Market Data 
Markets 
AI
